Familial occurrence of accessory atrioventricular pathways (preexcitation syndrome). Vidaillet HJ, Pressley JC, Henke E, Harrell FE, German LD (1987) N Engl J Med 317: 65-9 Genome-wide association study of multiple congenital heart disease phenotypes identifies a susceptibility locus for atrial septal defect at chromosome 4p16. Cordell HJ, Bentham J, Topf A, Zelenika D, Heath S, Mamasoula C, Cosgrove C, Blue G, Granados-Riveron J, Setchfield K, Thornborough C, Breckpot J, Soemedi R, Martin R, Rahman TJ, Hall D, van Engelen K, Moorman AF, Zwinderman AH, Barnett P, Koopmann TT, Adriaens ME, Varro A, George AL, dos Remedios C, Bishopric NH, Bezzina CR, O'Sullivan J, Gewillig M, Bu'Lock FA, Winlaw D, Bhattacharya S, Devriendt K, Brook JD, Mulder BJ, Mital S, Postma AV, Lathrop GM, Farrall M, Goodship JA, Keavney BD (2013) Nat Genet 45: 822-4 A rare variant in MYH6 is associated with high risk of sick sinus syndrome. Holm H, Gudbjartsson DF, Sulem P, Masson G, Helgadottir HT, Zanon C, Magnusson OT, Helgason A, Saemundsdottir J, Gylfason A, Stefansdottir H, Gretarsdottir S, Matthiasson SE, Thorgeirsson GM, Jonasdottir A, Sigurdsson A, Stefansson H, Werge T, Rafnar T, Kiemeney LA, Parvez B, Muhammad R, Roden DM, Darbar D, Thorleifsson G, Walters GB, Kong A, Thorsteinsdottir U, Arnar DO, Stefansson K (2011) Nat Genet 43: 316-20 Evaluating the yield of medical tests. Harrell FE, Califf RM, Pryor DB, Lee KL, Rosati RA (1982) JAMA 247: 2543-6 Anthracycline cardiotoxicity: from bench to bedside. Gianni L, Herman EH, Lipshultz SE, Minotti G, Sarvazyan N, Sawyer DB (2008) J Clin Oncol 26: 3777-84 Reply to R. Steiner et al. Lenihan D, Cardinale D (2013) J Clin Oncol 31: 1380 Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease. Tebbi CK, London WB, Friedman D, Villaluna D, De Alarcon PA, Constine LS, Mendenhall NP, Sposto R, Chauvenet A, Schwartz CL (2007) J Clin Oncol 25: 493-500 Late cardiac effects of cancer treatment. Lenihan DJ, Cardinale DM (2012) J Clin Oncol 30: 3657-64 The effect of cardiac hypertrophy on the coronary collateral circulation. Harrison DG, Barnes DH, Hiratzka LF, Eastham CL, Kerber RE, Marcus ML (1985) Circulation 71: 1135-45 AHA/ACCF Scientific Statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation: in collaboration with the Heart Rhythm Society: endorsed by the American Autonomic Society. Strickberger SA, Benson DW, Biaggioni I, Callans DJ, Cohen MI, Ellenbogen KA, Epstein AE, Friedman P, Goldberger J, Heidenreich PA, Klein GJ, Knight BP, Morillo CA, Myerburg RJ, Sila CA, American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, Quality of Care and Outcomes Research Interdisciplinary Working Group, American College of Cardiology Foundation, Heart Rhythm Society, American Autonomic Society (2006) Circulation 113: 316-27 ABCDE steps to prevent heart disease in breast cancer survivors. Montazeri K, Unitt C, Foody JM, Harris JR, Partridge AH, Moslehi J (2014) Circulation 130: e157-9 Cardiology patient page. Breast cancer chemotherapy and your heart. Unitt C, Montazeri K, Tolaney S, Moslehi J (2014) Circulation 129: e680-2 Noninvasive, in utero imaging of mouse embryonic heart development with 40-MHz echocardiography. Srinivasan S, Baldwin HS, Aristizabal O, Kwee L, Labow M, Artman M, Turnbull DH (1998) Circulation 98: 912-8 Pharmacogenomics: personalizing pediatric heart transplantation. Van Driest SL, Webber SA (2015) Circulation 131: 503-12 Cardiovascular effects of noncardiovascular drugs. Raj SR, Stein CM, Saavedra PJ, Roden DM (2009) Circulation 120: 1123-32 Cardiovascular complications of radiation therapy for thoracic malignancies: the role for non-invasive imaging for detection of cardiovascular disease. Groarke JD, Nguyen PL, Nohria A, Ferrari R, Cheng S, Moslehi J (2014) Eur Heart J 35: 612-23 Insights into (the interstitium of) degenerative aortic valve disease. Merryman WD (2008) J Am Coll Cardiol 51: 1415; author reply 1416 Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease. Denney WD, Kemp WE, Anthony LB, Oates JA, Byrd BF (1998) J Am Coll Cardiol 32: 1017-22 AHA/ACCF scientific statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation In Collaboration With the Heart Rhythm Society. Strickberger SA, Benson DW, Biaggioni I, Callans DJ, Cohen MI, Ellenbogen KA, Epstein AE, Friedman P, Goldberger J, Heidenreich PA, Klein GJ, Knight BP, Morillo CA, Myerburg RJ, Sila CA, American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, Quality of Care and Outcomes Research Interdisciplinary Working Group, American College of Cardiology Foundation, Heart Rhythm Society (2006) J Am Coll Cardiol 47: 473-84 Lack of cardiac manifestations among patients with previously treated Lyme disease. Sangha O, Phillips CB, Fleischmann KE, Wang TJ, Fossel AH, Lew R, Liang MH, Shadick NA (1998) Ann Intern Med 128: 346-53 Oxidized CaMKII: a "heart stopper" for the sinus node? Huke S, Knollmann BC (2011) J Clin Invest 121: 2975-7 Potential drug targets for calcific aortic valve disease. Hutcheson JD, Aikawa E, Merryman WD (2014) Nat Rev Cardiol 11: 218-31 Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. Becker BN, Himmelfarb J, Henrich WL, Hakim RM (1997) J Am Soc Nephrol 8: 475-86 Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury. Luther JM, Luo P, Wang Z, Cohen SE, Kim HS, Fogo AB, Brown NJ (2012) Kidney Int 82: 643-51 Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt. Lea WB, Kwak ES, Luther JM, Fowler SM, Wang Z, Ma J, Fogo AB, Brown NJ (2009) Kidney Int 75: 936-44 Serotonin receptors and heart valve disease--it was meant 2B. Hutcheson JD, Setola V, Roth BL, Merryman WD (2011) Pharmacol Ther 132: 146-57 Diabetes TV news coverage lags behind. Miller ST, Campbell MN, Pichert JW (2002) Diabetes Care 25: 607 Do fish oil omega-3 fatty acids enhance antioxidant capacity and mitochondrial fatty acid oxidation in human atrial myocardium via PPARγ activation? Anderson EJ, Thayne KA, Harris M, Shaikh SR, Darden TM, Lark DS, Williams JM, Chitwood WR, Kypson AP, Rodriguez E (2014) Antioxid Redox Signal 21: 1156-63 Clinical and molecular pharmacologic characteristics of adenosine-induced vasodilation. Biaggioni I (2004) Clin Pharmacol Ther 75: 137-9 Cadherin-11 regulates cell-cell tension necessary for calcific nodule formation by valvular myofibroblasts. Hutcheson JD, Chen J, Sewell-Loftin MK, Ryzhova LM, Fisher CI, Su YR, Merryman WD (2013) Arterioscler Thromb Vasc Biol 33: 114-20 Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease. Yutzey KE, Demer LL, Body SC, Huggins GS, Towler DA, Giachelli CM, Hofmann-Bowman MA, Mortlock DP, Rogers MB, Sadeghi MM, Aikawa E (2014) Arterioscler Thromb Vasc Biol 34: 2387-93 Biomarkers of cardiac injury in acute respiratory distress syndrome: getting to the heart of the matter. Girard TD, Ware LB (2007) Crit Care Med 35: 2638-9 A new age of discovery for plasma lipoproteins. Fazio S, Linton MF (2007) Curr Opin Lipidol 18: 387-8 Maternal and perinatal characteristics in relation to neuroblastoma. Chow EJ, Friedman DL, Mueller BA (2007) Cancer 109: 983-92 The association of mental health over time with cardiac outcomes in HEMO study patients. Kang EW, Pike F, Ramer S, Abdel-Kader K, Myaskovsky L, Dew MA, Unruh M (2012) Clin J Am Soc Nephrol 7: 957-64 ACE I/D polymorphism associated with abnormal atrial and atrioventricular conduction in lone atrial fibrillation and structural heart disease: implications for electrical remodeling. Watanabe H, Kaiser DW, Makino S, MacRae CA, Ellinor PT, Wasserman BS, Kannankeril PJ, Donahue BS, Roden DM, Darbar D (2009) Heart Rhythm 6: 1327-32 Performance of the 2010 European Society of Cardiology criteria for ECG interpretation in athletes. Weiner RB, Hutter AM, Wang F, Kim JH, Wood MJ, Wang TJ, Picard MH, Baggish AL (2011) Heart 97: 1573-7 Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease. Boudoulas KD, Hatzopoulos AK (2009) Dis Model Mech 2: 344-58 Modulation of cardiac function: titin springs into action. Lim CC, Sawyer DB (2005) J Gen Physiol 125: 249-52
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.